Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032753
Filing Date
2022-11-17
Accepted
2022-11-17 15:30:03
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 910463
2 ex31-1.htm EX-31.1 18880
3 ex31-2.htm EX-31.2 18498
4 ex32-1.htm EX-32.1 7223
5 ex32-2.htm EX-32.2 6860
  Complete submission text file 0001493152-22-032753.txt   3683880

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rtgn-20220930.xsd EX-101.SCH 24088
7 XBRL CALCULATION FILE rtgn-20220930_cal.xml EX-101.CAL 30648
8 XBRL DEFINITION FILE rtgn-20220930_def.xml EX-101.DEF 124007
9 XBRL LABEL FILE rtgn-20220930_lab.xml EX-101.LAB 245552
10 XBRL PRESENTATION FILE rtgn-20220930_pre.xml EX-101.PRE 202826
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 439029
Mailing Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954
Business Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954 415-578-9583
RetinalGenix Technologies Inc. (Filer) CIK: 0001836295 (see all company filings)

IRS No.: 823936890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-258528 | Film No.: 221398019
SIC: 3841 Surgical & Medical Instruments & Apparatus